NCDC on X: ""Healthcare workers should get familiar with the new guidelines to minimise the risk of nosocomial transmission of Lassa fever." ~ Following lessons from 2018, here is what #Nigeria did
![Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever | Nature Medicine Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnm.4396/MediaObjects/41591_2017_Article_BFnm4396_Fig1_HTML.jpg)
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever | Nature Medicine
![Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages | Scientific Reports Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-72539-w/MediaObjects/41598_2020_72539_Fig6_HTML.png)
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages | Scientific Reports
![Full article: Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments Full article: Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.1080%2F21505594.2021.2000290&id=kvir_a_2000290_uf0001_oc.jpg)
Full article: Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments
![Frontiers | Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice Frontiers | Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice](https://www.frontiersin.org/files/Articles/847598/fitd-03-847598-HTML/image_m/fitd-03-847598-g001.jpg)
Frontiers | Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice
![Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies - ScienceDirect Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124723005351-fx1.jpg)
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies - ScienceDirect
![Microorganisms | Free Full-Text | Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012–2019 Microorganisms | Free Full-Text | Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012–2019](https://pub.mdpi-res.com/microorganisms/microorganisms-09-00586/article_deploy/html/images/microorganisms-09-00586-g001.png?1616123540)